NO20005498D0 - Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstørrelse - Google Patents
Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstørrelseInfo
- Publication number
- NO20005498D0 NO20005498D0 NO20005498A NO20005498A NO20005498D0 NO 20005498 D0 NO20005498 D0 NO 20005498D0 NO 20005498 A NO20005498 A NO 20005498A NO 20005498 A NO20005498 A NO 20005498A NO 20005498 D0 NO20005498 D0 NO 20005498D0
- Authority
- NO
- Norway
- Prior art keywords
- ysulfonyl
- naphth
- piperazine
- pyridyl
- benzoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809350.3A GB9809350D0 (en) | 1998-05-02 | 1998-05-02 | Novel salt |
| PCT/GB1999/001316 WO1999057112A1 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005498L NO20005498L (no) | 2000-11-01 |
| NO20005498D0 true NO20005498D0 (no) | 2000-11-01 |
Family
ID=10831311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005498A NO20005498D0 (no) | 1998-05-02 | 2000-11-01 | Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstørrelse |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1084118A1 (no) |
| JP (1) | JP2002513789A (no) |
| KR (1) | KR20010043216A (no) |
| CN (1) | CN1308629A (no) |
| AU (1) | AU3719699A (no) |
| BR (1) | BR9910176A (no) |
| CA (1) | CA2331041A1 (no) |
| EE (1) | EE200000638A (no) |
| GB (1) | GB9809350D0 (no) |
| HU (1) | HUP0102394A3 (no) |
| IL (1) | IL139405A0 (no) |
| NO (1) | NO20005498D0 (no) |
| PL (1) | PL343705A1 (no) |
| SK (1) | SK16522000A3 (no) |
| WO (1) | WO1999057112A1 (no) |
| ZA (1) | ZA200006036B (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69833036T2 (de) * | 1997-09-30 | 2006-06-22 | Daiichi Pharmaceutical Co., Ltd. | Sulfonylderivate |
| TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| WO2003000657A1 (fr) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
| DK1569912T3 (en) | 2002-12-03 | 2015-06-29 | Pharmacyclics Inc | 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA56197C2 (uk) * | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
| ATE334975T1 (de) * | 1997-05-30 | 2006-08-15 | Takeda Pharmaceutical | Sulfonamidderivate, ihre herstellung und verwendung |
| DE69833036T2 (de) * | 1997-09-30 | 2006-06-22 | Daiichi Pharmaceutical Co., Ltd. | Sulfonylderivate |
-
1998
- 1998-05-02 GB GBGB9809350.3A patent/GB9809350D0/en not_active Ceased
-
1999
- 1999-04-27 EE EEP200000638A patent/EE200000638A/xx unknown
- 1999-04-27 PL PL99343705A patent/PL343705A1/xx not_active Application Discontinuation
- 1999-04-27 WO PCT/GB1999/001316 patent/WO1999057112A1/en not_active Application Discontinuation
- 1999-04-27 KR KR1020007012149A patent/KR20010043216A/ko not_active Application Discontinuation
- 1999-04-27 BR BR9910176-9A patent/BR9910176A/pt not_active IP Right Cessation
- 1999-04-27 IL IL13940599A patent/IL139405A0/xx unknown
- 1999-04-27 SK SK1652-2000A patent/SK16522000A3/sk unknown
- 1999-04-27 CA CA002331041A patent/CA2331041A1/en not_active Abandoned
- 1999-04-27 EP EP99919395A patent/EP1084118A1/en not_active Withdrawn
- 1999-04-27 CN CN99808217A patent/CN1308629A/zh active Pending
- 1999-04-27 JP JP2000547082A patent/JP2002513789A/ja active Pending
- 1999-04-27 HU HU0102394A patent/HUP0102394A3/hu unknown
- 1999-04-27 AU AU37196/99A patent/AU3719699A/en not_active Abandoned
-
2000
- 2000-10-25 ZA ZA200006036A patent/ZA200006036B/en unknown
- 2000-11-01 NO NO20005498A patent/NO20005498D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK16522000A3 (sk) | 2001-05-10 |
| WO1999057112A1 (en) | 1999-11-11 |
| EE200000638A (et) | 2002-04-15 |
| HUP0102394A2 (hu) | 2001-12-28 |
| HUP0102394A3 (en) | 2003-01-28 |
| ZA200006036B (en) | 2002-01-25 |
| IL139405A0 (en) | 2001-11-25 |
| NO20005498L (no) | 2000-11-01 |
| JP2002513789A (ja) | 2002-05-14 |
| BR9910176A (pt) | 2001-01-09 |
| GB9809350D0 (en) | 1998-07-01 |
| CN1308629A (zh) | 2001-08-15 |
| CA2331041A1 (en) | 1999-11-11 |
| EP1084118A1 (en) | 2001-03-21 |
| KR20010043216A (ko) | 2001-05-25 |
| AU3719699A (en) | 1999-11-23 |
| PL343705A1 (en) | 2001-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8405786A1 (es) | Un procedimiento para la preparacion de 1-(4,(4,4-dialquil-2,6-piperidindion-1-1l)butil)piperazinas. | |
| NO924764L (no) | 4-pyrimidinyl- og pyridinylderivater av indol-3-yl-alkylpiperazin | |
| DE60042710D1 (de) | Verwendung von 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazin und dessem physiologisch akzeptablen Salzen | |
| DE60142613D1 (de) | Aryl substituierte pyridinen, pyrimidinen, pyrazinen und triazinen und deren verwendung | |
| FI19991729A (fi) | 1-((4-Kloorifenyyli)fenyylimetyyli)-4-((4-metyylifenyyli)sulfonyyli)piperatsiinin enantiomeerit | |
| CH1175401H1 (de) | Piperazin Derivate verwendbar als CCR5 Antagonisten | |
| ATE415392T1 (de) | Pyrimidinonderivate und deren verwendung bei der behandlung von atherosklerose | |
| FI933804A0 (fi) | Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2h-indol-2-onkhydroklorid | |
| ATE343565T1 (de) | Phenyl- und pyridinyl-derivate verwendbar als neurokinin-1-antagonisten | |
| NO20000115L (no) | Gastrokinetiske monocykliske benzamidler av 3- eller 4- substituerte 4-(aminometyl)-piperidinderivater | |
| NO984380D0 (no) | Nye piperazin og piperidin forbindelser | |
| DK1131308T3 (da) | Piperazin- og piperidinderivater | |
| EE200100498A (et) | 1,4-asendatud piperasiin-, 1,4-asendatud piperidiin- ja 1-asendatud 4-alkülidenüülpiperidiinühendidning nende raviotstarbeline kasutamine | |
| DE69106388T2 (de) | Antipsychotische 4-(1,2-benzisoazolyl)piperidinderivate. | |
| ES8402832A1 (es) | Un procedimiento para la preparacion de compuestos dotados de propiedades psicotropicas. | |
| NO20025365D0 (no) | Piperazin- og piperidinforbindelser | |
| NO20005498D0 (no) | Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstørrelse | |
| SG127737A1 (en) | Piperidine and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases | |
| RS49904B (sr) | Pseudopolimorfni oblici 2-[2-[ 4- [bis( 4-fluorofenil)metil]-1-piperazinil]etoksi] sirćetne kiseline dihidrohlorida | |
| NO20000665D0 (no) | 2-{3-[4-(2-t-Butyl-6-trifluormetyl-4-pyrimidinyl)-1- piperazinyl]propyltio}-4-pyrimidinol-fumarat | |
| DE60204791D1 (de) | Synthese von 4-(piperidyl) (2-pyridyl)methanon-(e)-o-methyloxim und seinen salzen | |
| AU3793478A (en) | 4-[4-(2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl-methyl)-1-piperazinyl]-6-methyl pyrimidine derivatives | |
| AU2001225369A1 (en) | Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression | |
| AU2002359274A1 (en) | Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |